Clinical Trial Update: Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether dutasteride reduces the risk of acute urinary retention relapse after catheter removal in men with benign prostatic hyperplasia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Avodart (dutasteride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Benign Prostatic Hyperplasia | Phase 4 | Status: TERMINATED